American Journal of Medicine, internal medicine, medicine, health, healthy lifestyles, cancer, heart disease, drugs

30-Day Readmissions After an Acute Kidney Injury Hospitalization

nurse speaking to a patient in bed

The risk of hospital readmission in acute kidney injury survivors is not well understood. We estimated the proportion of acute kidney injury patients who were rehospitalized within 30 days and identified characteristics associated with hospital readmission.

Methods

We conducted a population-based study of patients who survived a hospitalization complicated by acute kidney injury from 2003-2013 in Ontario, Canada. The primary outcome was 30-day hospital readmission. We used a propensity score model to match patients with and without acute kidney injury, and a Cox proportional hazards model with death as a competing risk to identify predictors of 30-day readmission.

Results

We identified 156,690 patients who were discharged from 197 hospitals after an episode of acute kidney injury. In the subsequent 30 days, 27,457 (18%) patients were readmitted; 15,988 (10%) visited the emergency department and 7480 (5%) died. We successfully matched 111,778 patients with acute kidney injury 1:1 to patients without acute kidney injury. The likelihood of 30-day readmission was higher in acute kidney injury patients than those without acute kidney injury (hazard ratio [HR] 1.53; 95% confidence interval [CI], 1.50-1.57). Factors most strongly associated with 30-day rehospitalization were the number of hospitalizations in the preceding year (adjusted HR 1.45 for ≥2 hospitalizations; 95% CI, 1.40-1.51) and receipt of inpatient chemotherapy (adjusted HR 1.44; 95% CI, 1.32-1.58).

Conclusions

One in 5 patients who survive a hospitalization complicated by acute kidney injury is readmitted in the next 30 days. Better strategies are needed to identify and care for acute kidney injury survivors in the community.

To read this article in its entirety please visit our website.

-Samuel A. Silver, MD, MSc, Ziv Harel, MD, MSc, Eric McArthur, MSc, Danielle M. Nash, MSc, Rey Acedillo, MD, Abhijat Kitchlu, MD, Amit X. Garg, MD, PhD, Glenn M. Chertow, MD, MPH, Chaim M. Bell, MD, PhD1, Ron Wald, MDCM, MPH1

This article originally appeared in the February 2017 issue of The American Journal of Medicine.

Comments are closed.

UA-42320404-1